Skip to main content

Table 1 Transition rates between chronic hepatitis B and diseases [13]

From: Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

 

Decompensated cirrhosis

Hepatocellular cancer

Transplantation

Death (%)

Compensated cirrhosis

7.3 %

3.4 %

0.0 %

4.9

Decompensated cirrhosis

–

3.4 %

20.0 %

19.0

Hepatocellular cancer

–

–

25.0 %

43.3

transplantation

–

–

–

6.9